Skip to main content

GLP-1 side effects: what to expect

Every medication has a side-effect profile, and GLP-1 receptor agonists are no exception. Most side effects are gastrointestinal and tend to be mild-to-moderate. Some are serious and require immediate provider contact. This page covers both — plainly.

Common side effects

The most frequently reported side effects are gastrointestinal. They are generally mild-to-moderate in severity and often ease as your body adjusts over the first weeks of treatment:

Nausea — The most common — often most noticeable in early treatment or after dose increases.

Diarrhea — Reported frequently; usually self-limiting as the body adjusts.

Vomiting — Less common than nausea; more likely at higher doses.

Dyspepsia (indigestion) — Bloating, fullness, or discomfort after eating.

Decreased appetite — Intended therapeutic effect; also classified as an adverse event in trials.

If any side effect is persistent, worsening, or affecting your daily functioning, contact your licensed provider — do not self-manage.

Serious class warnings to know

FDA Boxed Warning — Thyroid C-cell tumors

GLP-1 receptor agonists carry an FDA boxed warning for thyroid C-cell tumor risk (the highest-level FDA safety warning). These medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Source: FDA prescribing information for GLP-1 receptor agonists. Always disclose your full personal and family medical history to your licensed provider before starting treatment.

Other serious but less common events reported in clinical programmes include pancreatitis, gallbladder disease, and hypoglycaemia (particularly when combined with other glucose-lowering medications). Your prescribing provider reviews these risks as part of a clinical evaluation.

When to contact your provider or seek care

Do not wait it out or self-adjust if you experience any of the following:

Persistent or severe nausea, vomiting, or abdominal pain — contact your provider promptly.

Signs of pancreatitis: severe abdominal pain that may radiate to your back — seek care immediately.

Signs of a serious allergic reaction: swelling of face, lips, tongue, or throat; difficulty breathing — call 911.

A lump or swelling in your neck, hoarseness, difficulty swallowing — contact your provider.

Any side effect that is worsening, not improving, or significantly impacting your daily life — contact your provider before making any changes.

Common questions

What are the most common GLP-1 side effects?

Gastrointestinal effects — nausea, diarrhea, vomiting, and decreased appetite — are the most commonly reported. They are generally mild-to-moderate and often ease as the body adjusts over time.

Are there serious GLP-1 warnings I should know about?

Yes. GLP-1 receptor agonists carry an FDA boxed warning for thyroid C-cell tumor risk. They should not be used by people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Discuss your full history with a licensed provider before starting treatment.

What should I do if I have side effects?

Contact your licensed provider. For a medical emergency — such as signs of a serious allergic reaction or severe abdominal pain — call 911 or go to the nearest emergency room immediately. This page is educational, not medical advice.